Concepedia

Myo Htut

MH

12

Publications

452

Citations

11

H-Index

2022

Active since

Affiliations

City of Hope(Current)

Memorial Sloan Kettering Cancer Center

WinnMed

Dana-Farber Cancer Institute

Sarah Cannon

Myo Htut is an author at City of Hope specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2022–2025

12

Publications

12

Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2023 · 127 citations · Full text

, , +15

BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Susan Bal, Myo Htut, Omar Nadeem et al. · Blood · 2023 · 55 citations

Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · PubMed · 2023 · 43 citations

, , +11

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Michael Rainone, Dat Ngo, John H. Baird et al. · Blood Advances · 2022 · 40 citations · Full text

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

Sundar Jagannath, Thomas G. Martin, Yi Lin et al. · Journal of Clinical Oncology · 2025 · 40 citations · Full text

Rows per page

1–5 of 12